Axcel Mometasone Nasal Spray

Axcel Mometasone Nasal Spray Overdosage

mometasone

Manufacturer:

Kotra Pharma

Distributor:

Kotra Pharma
Full Prescribing Info
Overdosage
Because of the negligible (≤0.1%) systemic bioavailability of Axcel Mometasone 0.05%w/w Nasal Spray, overdose is unlikely to require any therapy other than observation, followed by initiation of the appropriate prescribed dosage.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in